Progyny (PGNY) Tops Q2 EPS by 26c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Progyny (PGNY) PT Lowered to $33 at Truist Securities
August 7, 2024 6:30 AM EDTTruist Securities analyst Jailendra Singh lowered the price target on Progyny (NASDAQ: PGNY) to $33.00 (from $37.00) while maintaining a Buy rating.
The analyst comments "We had a post-quarterly conference call with PGNY management to discuss 2Q24 results, ART cycles per utilizer trends, its 2024... More
BTIG Downgrades Progyny (PGNY) to Neutral
August 7, 2024 5:23 AM EDTBTIG analyst David Larsen downgraded Progyny (NASDAQ: PGNY) from Buy to Neutral.
The analyst comments "We are downgrading Progyny (PGNY) to Neutral, following the company's 2Q:24 earnings report. 2Q24 revenue of $304.1M compares to BTIG / consensus of $306.5M / $305M, and EBITDA of $54.5M compares to BTIG / consensus of $53M/ $53M. Despite the... More
